STOCK TITAN

iRhythm Holdings, Inc Financials

IRTC
Trailing 12 months to June 30, 2026
Revenue $825.3M +25.6% YoY
Net Income -$14.4M +84.4% YoY
EPS (Diluted) -$0.42 +85.7% YoY
Free Cash Flow $39.0M +39.8% YoY
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

iRhythm Holdings, Inc (IRTC) reported $825.3M in revenue over the twelve months to Jun 30, 2026, up 25.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 12 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI IRTC FY2025

iRhythm’s scaling revenue base is finally absorbing fixed operating costs, pushing cash flow positive before reported earnings fully catch up.

Between FY2024 and FY2025, gross margin expansion and revenue growing faster than SG&A sharply reduced the operating loss, which points to better fixed-cost absorption rather than a simple one-time accounting lift. At the same time, free cash flow flipped from -$30.6M to $34.5M, showing the business has started to fund itself in cash terms even while GAAP net income remained negative.

The balance-sheet posture still reflects a major financing reset: liabilities were $867.3M against equity of only $152.7M, so the operating improvement is sitting on a much thinner equity cushion than earlier in the period. That helps explain why return on equity can look extreme even as losses narrow.

Liquidity is not tight—cash was $236.0M and the current ratio was 4.6x. But investing outflows of $277.1M were far larger than capital spending alone, so positive free cash flow did not translate into a higher cash balance; the company is now generating cash from operations while still deploying substantial cash elsewhere.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 44 / 100
Financial Health Score 44/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of iRhythm Holdings, Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
32

iRhythm Holdings, Inc has an operating margin of -7.7%, meaning the company loses $8 on every $100 of revenue. This results in a profitability score of 32/100. This is up from -19.5% the prior year.

Growth
84

iRhythm Holdings, Inc's revenue surged 26.2% year-over-year to $747.1M, reflecting rapid business expansion. This strong growth earns a score of 84/100.

Leverage
9

iRhythm Holdings, Inc has elevated debt relative to equity (D/E of 5.68), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 9/100, reflecting increased financial risk.

Liquidity
89

With a current ratio of 4.63, iRhythm Holdings, Inc holds $4.63 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 89/100.

Cash Flow
23

iRhythm Holdings, Inc's free cash flow margin of 4.6% results in a low score of 23/100. Capital expenditures of $46.3M absorb a large share of operating cash flow.

Returns
29

iRhythm Holdings, Inc posts a -29.5% return on equity (ROE), meaning it loses $29 for every $100 of shareholders' equity. This results in a returns score of 29/100. This is up from -124.3% the prior year.

Altman Z-Score Grey Zone
2.74

iRhythm Holdings, Inc scores 2.74, placing it in the grey zone between 1.81 and 2.99. The score is driven primarily by a large market capitalization ($3.8B) relative to total liabilities ($867.3M). This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
5/8

iRhythm Holdings, Inc passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Mixed
N/A

iRhythm Holdings, Inc reported a net loss of $45.0M while generating $80.9M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

iRhythm Holdings, Inc reported an operating loss of $57.4M against $13.2M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$747.1M
YoY+26.2%
5Y CAGR+23.0%
10Y CAGR+35.4%

iRhythm Holdings, Inc generated $747.1M in revenue in fiscal year 2025. This represents an increase of 26.2% from the prior year.

EBITDA
-$36.7M
YoY+61.3%

iRhythm Holdings, Inc's EBITDA was -$36.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 61.3% from the prior year.

Net Income
-$45.0M
YoY+60.2%

iRhythm Holdings, Inc reported -$45.0M in net income in fiscal year 2025. This represents an increase of 60.2% from the prior year.

EPS (Diluted)
-$1.39
YoY+61.7%

iRhythm Holdings, Inc earned -$1.39 per diluted share (EPS) in fiscal year 2025. This represents an increase of 61.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$34.5M
YoY+213.0%

iRhythm Holdings, Inc generated $34.5M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 213.0% from the prior year.

Cash & Debt
$236.0M
YoY-43.8%
5Y CAGR+21.6%
10Y CAGR+25.1%

iRhythm Holdings, Inc held $236.0M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Shares Outstanding
32M
YoY+2.9%
5Y CAGR+2.1%

iRhythm Holdings, Inc had 32M shares outstanding in fiscal year 2025. This represents an increase of 2.9% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
70.6%
YoY+1.7pp
5Y CAGR-2.9pp
10Y CAGR+11.3pp

iRhythm Holdings, Inc's gross margin was 70.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 1.7 percentage points from the prior year.

Operating Margin
-7.7%
YoY+11.8pp
5Y CAGR+8.8pp
10Y CAGR+52.2pp

iRhythm Holdings, Inc's operating margin was -7.7% in fiscal year 2025, reflecting core business profitability. This is up 11.8 percentage points from the prior year.

Net Margin
-6.0%
YoY+13.1pp
5Y CAGR+10.5pp
10Y CAGR+57.1pp

iRhythm Holdings, Inc's net profit margin was -6.0% in fiscal year 2025, showing the share of revenue converted to profit. This is up 13.1 percentage points from the prior year.

Return on Equity
-29.5%
YoY+94.8pp
5Y CAGR-16.6pp

iRhythm Holdings, Inc's ROE was -29.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 94.8 percentage points from the prior year.

Capital Allocation

R&D Spending
$84.6M
YoY+18.4%
5Y CAGR+15.4%
10Y CAGR+29.6%

iRhythm Holdings, Inc invested $84.6M in research and development in fiscal year 2025. This represents an increase of 18.4% from the prior year.

Share Buybacks
$0
YoY-100.0%

iRhythm Holdings, Inc repurchased no shares in fiscal year 2025. This represents a decrease of 100.0% from the prior year.

Capital Expenditures
$46.3M
YoY+36.5%
5Y CAGR+27.9%
10Y CAGR+38.5%

iRhythm Holdings, Inc invested $46.3M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 36.5% from the prior year.

IRTC Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

IRTC quarterly income statement
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Revenue$224.2M+12.4%$199.4M-4.5%$208.9M+8.3%$192.9M+3.3%$186.7M+17.7%$158.7M-3.4%$164.3M+11.4%$147.5M
Cost of Revenue$61.0M+5.0%$58.0M-4.6%$60.8M+9.1%$55.8M+3.6%$53.8M+8.8%$49.5M+0.4%$49.3M+6.9%$46.1M
Gross Profit$163.2M+15.5%$141.4M-4.5%$148.1M+8.0%$137.1M+3.2%$132.9M+21.6%$109.2M-5.1%$115.1M+13.4%$101.5M
R&D Expenses$19.8M-7.1%$21.4M+1.5%$21.0M+0.1%$21.0M+0.1%$21.0M-2.4%$21.5M+12.8%$19.1M+21.6%$15.7M
SG&A Expenses$131.7M-3.1%$135.9M+11.4%$122.0M-1.8%$124.2M-1.7%$126.4M+5.4%$120.0M+20.2%$99.8M-3.5%$103.4M
Operating Income-$2.5M+84.3%-$16.2M-808.0%$2.3M+127.1%-$8.4M+54.9%-$18.7M+42.5%-$32.6M-697.4%-$4.1M+91.9%-$50.3M
Interest Expense$3.3M+0.2%$3.3M-1.0%$3.3M+1.2%$3.3M+0.1%$3.3M+0.2%$3.3M-4.5%$3.4M+4.7%$3.3M
Income Tax$0-100.0%$500K+11.9%$447K+1762.5%$24K+113.1%-$183K-127.5%$665K+340.4%$151K-19.7%$188K
Net Income-$381K+97.3%-$13.9M-371.6%$5.1M+198.4%-$5.2M+63.3%-$14.2M+53.7%-$30.7M-2840.6%-$1.0M+97.7%-$46.2M
EPS (Diluted)-$0.01+97.7%-$0.43-338.9%$0.18+212.5%-$0.16+63.6%-$0.44+54.6%-$0.97-2325.0%-$0.04+97.3%-$1.48

IRTC Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

IRTC quarterly balance sheet
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Total Assets$1.1B+8.7%$1.0B-1.3%$1.0B+2.5%$995.2M+3.2%$964.0M+4.1%$926.1M-0.6%$931.4M+2.4%$909.7M
Current Assets$756.0M+11.1%$680.6M-3.2%$702.8M+3.3%$680.0M+2.4%$663.9M+4.4%$636.0M-1.5%$645.8M+2.9%$627.9M
Cash & Equivalents$246.7M+2.7%$240.1M+1.8%$236.0M-7.7%$255.6M-17.3%$309.1M-17.6%$375.3M-10.6%$419.6M-19.2%$519.5M
Inventory$22.5M-5.4%$23.8M+10.0%$21.6M+10.6%$19.6M+6.3%$18.4M+28.3%$14.3M+2.1%$14.0M-6.6%$15.0M
Accounts Receivable$84.3M+4.2%$80.9M+6.8%$75.7M-0.6%$76.2M-7.3%$82.2M+1.9%$80.6M+0.9%$79.9M+3.2%$77.4M
Goodwill$862K0.0%$862K0.0%$862K0.0%$862K0.0%$862K0.0%$862K0.0%$862K0.0%$862K
Total Liabilities$907.4M+7.4%$845.2M-2.6%$867.3M-0.7%$873.3M+1.5%$860.4M+2.5%$839.4M-0.1%$840.5M+0.3%$837.9M
Current Liabilities$196.1M+48.8%$131.8M-13.3%$151.9M+3.4%$146.9M+11.1%$132.2M+18.7%$111.3M+0.4%$110.9M+10.8%$100.1M
Total Equity$186.0M+15.4%$161.2M+5.5%$152.7M+25.3%$121.9M+17.6%$103.7M+19.6%$86.7M-4.7%$90.9M+26.7%$71.8M
Retained Earnings-$817.8M0.0%-$817.4M-1.7%-$803.4M+0.7%-$809.0M-0.6%-$803.8M-1.8%-$789.6M-4.0%-$758.9M-0.2%-$757.6M

Not reported in any period shown, so not listed: Long-Term Debt.

IRTC Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

IRTC quarterly cash flow statement
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Operating Cash Flow$51.1M+295.2%-$26.2M-199.9%$26.2M-24.9%$34.9M+26.1%$27.7M+450.5%-$7.9M-141.0%$19.2M-21.0%$24.3M
Capital Expenditures$13.6M+96.5%$6.9M-41.1%$11.7M-21.0%$14.8M+43.0%$10.4M+10.1%$9.4M+37.6%$6.8M-22.5%$8.8M
Free Cash Flow$37.5M+213.4%-$33.1M-328.3%$14.5M-27.7%$20.1M+16.0%$17.3M+199.9%-$17.3M-239.7%$12.4M-20.1%$15.5M
Investing Cash Flow-$48.6M-261.0%$30.2M+161.9%-$48.8M+45.3%-$89.2M+11.6%-$100.9M-164.6%-$38.1M+68.8%-$122.2M-120.8%-$55.3M
Financing Cash Flow$4.1M+2638.3%$149K-95.0%$3.0M+258.7%$825K-88.4%$7.1M+310.3%$1.7M-42.1%$3.0M+8634.3%-$35K
Share BuybacksN/AN/A$0$0$0$0$0$0

Not reported in any period shown, so not listed: Dividends Paid.

IRTC Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

IRTC quarterly financial ratios
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Gross Margin72.8%+1.9pp70.9%0.0pp70.9%-0.2pp71.1%-0.1pp71.2%+2.3pp68.8%-1.2pp70.0%+1.2pp68.8%
Operating Margin-1.1%+7.0pp-8.1%-9.2pp1.1%+5.5pp-4.4%+5.6pp-10.0%+10.5pp-20.5%-18.0pp-2.5%+31.6pp-34.1%
Net Margin-0.2%+6.8pp-7.0%-9.4pp2.5%+5.2pp-2.7%+4.9pp-7.6%+11.7pp-19.4%-18.7pp-0.6%+30.7pp-31.3%
Return on Equity-0.2%+8.4pp-8.6%-12.0pp3.4%+7.6pp-4.3%+9.4pp-13.7%+21.7pp-35.4%-34.3pp-1.1%+63.2pp-64.3%
Return on Assets0.0%+1.4pp-1.4%-1.9pp0.5%+1.0pp-0.5%+0.9pp-1.5%+1.8pp-3.3%-3.2pp-0.1%+5.0pp-5.1%
Current Ratio3.85-1.3x5.17+0.5x4.630.0x4.63-0.4x5.02-0.7x5.71-0.1x5.82-0.5x6.27
Debt-to-Equity4.88-0.4x5.24-0.4x5.68-1.5x7.16-1.1x8.30-1.4x9.69+0.4x9.25-2.4x11.68
FCF Margin16.7%+33.3pp-16.6%-23.5pp6.9%-3.5pp10.4%+1.1pp9.3%+20.2pp-10.9%-18.4pp7.5%-3.0pp10.5%

Similar Companies

Frequently Asked Questions

What is iRhythm Holdings, Inc's annual revenue?

iRhythm Holdings, Inc (IRTC) reported $747.1M in total revenue for fiscal year 2025. This represents a 26.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is iRhythm Holdings, Inc's revenue growing?

iRhythm Holdings, Inc (IRTC) revenue grew by 26.2% year-over-year, from $591.8M to $747.1M in fiscal year 2025.

Is iRhythm Holdings, Inc profitable?

No, iRhythm Holdings, Inc (IRTC) reported a net income of -$45.0M in fiscal year 2025, with a net profit margin of -6.0%.

iRhythm Holdings, Inc (IRTC) reported diluted earnings per share of -$1.39 for fiscal year 2025. This represents a 61.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

iRhythm Holdings, Inc (IRTC) had EBITDA of -$36.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

iRhythm Holdings, Inc (IRTC) had a gross margin of 70.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

iRhythm Holdings, Inc (IRTC) had an operating margin of -7.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

iRhythm Holdings, Inc (IRTC) had a net profit margin of -6.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

iRhythm Holdings, Inc (IRTC) has a return on equity of -29.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

iRhythm Holdings, Inc (IRTC) generated $34.5M in free cash flow during fiscal year 2025. This represents a 213.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

iRhythm Holdings, Inc (IRTC) generated $80.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

iRhythm Holdings, Inc (IRTC) had $1.0B in total assets as of fiscal year 2025, including both current and long-term assets.

iRhythm Holdings, Inc (IRTC) invested $46.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

iRhythm Holdings, Inc (IRTC) invested $84.6M in research and development during fiscal year 2025.

iRhythm Holdings, Inc (IRTC) had 32M shares outstanding as of fiscal year 2025.

iRhythm Holdings, Inc (IRTC) had a current ratio of 4.63 as of fiscal year 2025, which is generally considered healthy.

iRhythm Holdings, Inc (IRTC) had a debt-to-equity ratio of 5.68 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

iRhythm Holdings, Inc (IRTC) had a return on assets of -4.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

iRhythm Holdings, Inc (IRTC) has an Altman Z-Score of 2.74, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

iRhythm Holdings, Inc (IRTC) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

iRhythm Holdings, Inc (IRTC) reported a net loss of $45.0M while generating $80.9M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

iRhythm Holdings, Inc (IRTC) reported an operating loss of $57.4M against $13.2M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

iRhythm Holdings, Inc (IRTC) scores 44 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top